Previous Section Back to Table of Contents Lords Hansard Home Page


Lord Lucas asked Her Majesty's Government:

Lord Hunt of Kings Heath: All definite and probable cases of vCJD reported by the National CJD Surveillance Unit have been found to be methionine/methionine homozygous at codon 129 for the prion protein.

16 Oct 2000 : Column WA74

Degenerative Diseases: Research Expenditure

Lord Elton asked Her Majesty's Government:

    For each of the last five years for which figures are available, how many deaths were recorded respectively in England, Wales and Northern Ireland as the result of (a) multiple sclerosis, (b) CJD, and (c) AIDS; what was the total amount of expenditure by the Government in the United Kingdom on research into the identification, treatment, prevention and cure of these diseases; and what were the criteria on which this expenditure was allocated.[HL4021]

Lord Hunt of Kings Heath: Number of deaths

The figures for deaths from Multiple Sclerosis, CJD and AIDS in Northern Ireland and Wales are the responsibility of the devolved administrations.

Multiple Sclerosis

The following are numbers of deaths for England where the underlying cause of death was multiple sclerosis. (International Classification of Diseases code 340, Ninth revision.)

Deaths are for usual residents of England and do not include deaths of non-residents.

Year of deathEngland
1995638
1996701
1997660
1998698
1999721


    CJD

The number of deaths for England over the last five years is*:

YearEngland
199651
199767
199874
199963
200043

*confirmed and probable cases

16 Oct 2000 : Column WA75

AIDS

The number of deaths for England over the last five years recorded by the Public Health Laboratory Service in England due to HIV/AIDS*

Year of deathEngland
19961,236
1997571
1998419
1999363
2000¡145

*Includes AIDS deaths and deaths without reported AIDS (in those known to be HIV infected).

(6)Reported in the first two quarters of the year. Numbers, particularly for recent years, will rise as further reports are received.


Research

The figures are (£million):

YearMultiple Sclerosis(7)TSEs [including CJD](8)AIDS(9)
1990-2000£1.425m£31.5m£20.4m
1998-99£0.77m£21.8m£16.2m
1997-98£0.783m£16.2m£15.4m
1996-97£0.172m£10.8m£19.5m
1995-96£0.095m£10.0m£20.6m

The Multiple Sclerosis (MS) figure includes spend on basic work on a whole range of autoimmune disease, one of which is MS.

The AIDS figure consists of the spend in both the UK and overseas and both basic and applied research in the area.

Criteria on which this expenditure was allocated:

Decisions on research expenditure in these areas were made on the basis of the priorities of the individual government department or research council involved in the three areas and in relation to the quality of research proposals received.

Footnote:

1. Department of Health and Medical Research Council (MRC) expenditure.

2. MAFF (Ministry of Agriculture, Fisheries & Food), BBSRC (Biotechnology and Biological Sciences Research Council), MRC, Department of Health expenditure including Scottish Office Contribution to Surveillance to CJD Unit.

3. Department of Health, Scottish Office, Welsh Office, MRC and other research councils.




   Back to Table of Contents Lords Hansard Home Page